医療従事者の為の最新医療ニュースや様々な情報・ツールを提供する医療総合サイト

Next-Generation Large Molecule Affinity Purification Solution Improves Biotherapeutic, Disease Biomarker and Sports Anti-Doping Bioanalysis

2016年02月17日 PM10:30
このエントリーをはてなブックマークに追加


 

WALTHAM, Mass.

A new, fully automated affinity purification solution is designed to enable scientists to analyze large biomolecules, such as proteins and antibodies, with improved accuracy, consistency and simplicity, even at high throughputs.

This Smart News Release features multimedia. View the full release here: http://www.businesswire.com/news/home/20160217005001/en/

Thermo Scientific MSIA (Mass Spectrometric Immunoassay) Strepdavidin EVO microcolumn pipette technol ...

Thermo Scientific MSIA (Mass Spectrometric Immunoassay) Strepdavidin EVO microcolumn pipette technology used with Tecan EVO Freedom robotic platform for an automated affinity purification solution. (Photo: Business Wire)

The new Thermo Scientific MSIA Strepdavidin EVO microcolumns have been designed to bring the novel mass spectrometric immunoassay (MSIA) affinity purification technology to Tecan’s Freedom EVO series of robotic platforms that are equipped with a 96 multichannel arm (MCA96).

Biopharmaceutical, translational, clinical and sports anti-doping labs performing high-throughput characterization of large molecules are commonly challenged by the limitations of conventional affinity purification methods. These challenges include low efficiency, inconsistent results, high background and carryover and the inability to standardize methods and transfer between labs. As a result, researchers often invest time in generating data that may not reflect the accuracy needed.

When combined with the Tecan Freedom EVO robotic platform, MSIA Streptavidin EVO microcolumns enable fast and accurate isolation of target analytes from complex biological matrices. Housed within a pipette tip, the proprietary monolithic columns are densely coated with streptavidin for analytical affinity purification of any biotinylated affinity ligand, even at low concentration. Since this technology is incorporated into a pipette tip, users can analyze sample volumes as low as 10 µL, saving precious samples. Furthermore, when compared to traditional resin and bead-based methods, MSIA technology provides lower background noise and improved analytical sensitivity, while the simple workflow enables easier method standardization and transfer between labs.

“The MSIA Streptavidin EVO microcolumn is an ideal solution for biologics and biosimilars discovery and development,” said Preeti Saini, product manager for MSIA liquid handling consumables at Thermo Fisher Scientific. “It is particularly well suited to laboratories performing large molecule bioanalyses that demand high-quality, reproducible and unambiguous results with minimal background noise. Moreover, this solution is designed to help scientists save both precious samples and time.”

“Our combined solution will provide these laboratories with faster assay development, scalable sample processing and surety of data quality and consistency,” added Rohit Shroff, product manager for Tecan. “By bringing together Tecan’s well-established Freedom EVO workstations and Thermo Scientific MSIA technology, we can better cater to the high-volume bioanalytical research market.”

Until now, the MSIA technology has been exclusively available for use with the Thermo Scientific Versette Automated Liquid Handler and Thermo Scientific Finnpipette Novus i Multichannel Electronic Pipette for high- and low-throughput applications, respectively. The MSIA Streptavidin EVO microcolumns have been designed to enable a broader community of high-throughput bioanalytical researchers to benefit from automated liquid handling for large molecule bioanalytical assay development.

For more information on the MSIA technology and how MSIA workflow solutions enable highly reproducible and sensitive testing of large molecule analysis, please visit: https://www.thermoscientific.com/content/tfs/en/products/mass-spectrometric-immunoassay.html?wt.mc_id=lhc_msia_banner_prfirm_0116a.

For more information on Tecan’s robotic liquid handling solutions, please visit www.tecan.com/analyticalchemistry.

About Thermo Fisher Scientific
Thermo Fisher Scientific Inc. is the world leader in serving science, with revenues of $17 billion and approximately 50,000 employees in 50 countries. Our mission is to enable our customers to make the world healthier, cleaner and safer. We help our customers accelerate life sciences research, solve complex analytical challenges, improve patient diagnostics and increase laboratory productivity. Through our premier brands – Thermo Scientific, Applied Biosystems, Invitrogen, Fisher Scientific and Unity Lab Services – we offer an unmatched combination of innovative technologies, purchasing convenience and comprehensive support. For more information, please visit www.thermofisher.com.

View source version on businesswire.com: http://www.businesswire.com/news/home/20160217005001/en/

CONTACT

Thermo Fisher Scientific
Lisa Robillard, +1 781-790-7324
lisa.robillard@thermofisher.com
or
Chempetitive/BioStrata
Carolyn
Butchers, +44 (0) 1223 828200
cbutchers@biostratamarketing.com

同じカテゴリーの記事 

  • パース・バイオサイエンシズ、シングル・セル免疫プロファイリング製品を発表
  • Parse Biosciences推出单细胞免疫分析产品
  • ImmunityBio, Serum Institute of India Agree on an Exclusive Arrangement for Global Supply of Bacillus Calmette-Guerin (BCG) Across All Cancer Types
  • Asahi Kasei Bioprocess to Unveil THESYS™ ACS ERGO Synthesis Column at TIDES USA
  • マリアナ・オンコロジー、 ノバルティスによる買収で精密放射性療法によるがん治療を加速